Cannabinoid type 1 receptor antagonists for smoking cessation

摘要

BackgroundSelective type 1 cannabinoid (CB1) receptor antagonists may assist with smoking cessation by restoring the balance of the endocannabinoid system, which can be disrupted by prolonged use of nicotine. They also seek to address many smokers' reluctance to persist with a quit attempt because of concerns about weight gain.